Skip to main content
ACON logo

ACON · Aclarion, Inc. · Financials

Track ACON — free
$2.38 -0.06 (-2.46%) At close · Oct 2
Market Cap
$7.62M
Shares
2.88M
Volume · Oct 2 15.75K Avg daily vol (3M) 53.29K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$75.73K +65.6%
FY2025 Revenue FY2021–FY2025
Net Income
-$7.23M -3.4%
FY2025 Net Income FY2021–FY2025
Gross Margin
9.02% +94.2pp
FY2025 Gross Margin FY2021–FY2025
Operating Margin
-9312.55% +2744.7pp
FY2025 Operating Margin FY2021–FY2025
Diluted EPS
-$13.61 +99.8%
FY2025 Diluted EPS FY2021–FY2025
Operating Cash Flow
-$7.16M -35.9%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021
$83.77K $75.73K $45.72K $75.4K $60.44K $60.29K
$65.55K $68.9K $84.66K $75.73K $65.3K $69.18K
$18.22K $6828 -$38.93K -$324 -$4854 -$8883
— 9.02% -85.15% -0.43% -8.03% -14.73%
$1.18M $1.03M $888.77K $873.34K $1.07M $787.85K
$3.04M $1.9M $976.55K $757K $498K $330.81K
$5.51M $4.12M $3.61M $3.25M $3.99M $1.83M
$236.37K $224.55K $191.74K $161.11K $139.12K $126.39K
$242.46K $227.41K $193.14K $162.67K $143.62K $186.39K
$9.73M $7.06M $5.47M $4.88M $5.56M $2.94M
-$9.71M -$7.05M -$5.51M -$4.88M -$5.56M -$2.95M
— -9312.55% -12057.23% -6466.48% -9201.19% -4897.89%
-$9.47M -$6.82M -$5.32M -$4.71M -$5.42M -$2.77M
— — $64.08K $110.53K $1.51M $474.91K
$514.06K -$181.24K -$1.48M -$35.39K -$1.51M -$2M
-$9.2M -$7.23M -$6.99M -$4.91M -$7.07M —
$0 $0 $0 $0 $0 $0
-$9.2M -$7.23M -$6.99M -$4.91M -$7.07M -$4.95M
— -9551.87% -15293.78% -6513.41% -11694.45% -8210.53%
-$9.2M -$7.24M -$7.05M -$4.91M -$7.48M -$5.96M
USD/shares -$4.00 -$13.61 -$7,478.90 -$79,782.00 -$177,372.45 -$952,257.60
USD/shares -$4.00 -$13.61 -$7,478.90 -$79,782.00 -$177,372.45 -$952,257.60
shares — 532.04K 943 62 42.1888 6.2582
shares — 532.04K 943 62 42.1888 6.2582
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Noncurrent convertible notes payable 2025-12-31 USD 0 10-K filed 2026-03-18
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Peer median 0.60×
EV/EBIT
—
P/E (TTM)
—

Peer medians compare against the 18 similar-size Health Information Services companies (of 50 listed).

Key facts CIK 1635077 CUSIP 655187409 Visit website Investor relations